This review critically evaluates recent advances in understanding the role of epigenetics in nutrition.
INTRODUCTION
Traditionally, nutritional recommendations have been population based, only differentiating between age, sex and pregnancy. During the past two decades there has been a rapid increase in studies, which have reported associations between gene polymorphisms, nutrition and disease risk [1] . This paradigm shift in understanding the individual variation in nutritional requirements, which underpins the field of nutrigenomics has been driven, at least in part, by the advent of technology for assessing the relationship between risk factors and polymorphisms at the whole genome level. Although the 'personalised nutrition' approach to dietary recommendations may have the potential for decreasing the burden of nutrition-related diseases, the practical and economic challenges associated with this strategy are considerable.
A number of recent reports that have questioned the extent to which single nucleotide polymorphisms can explain the variation in risk for individual complex disease traits [2] . The emerging field of epigenetics has the potential to explain such unaccounted for variation in disease risk and so add a further level of complexity to the understanding of the interaction between nutrition and the genome [3] . The purpose of this review is to discuss recent developments in the field of epigenetics and nutrition, and to consider the potential contribution of this emerging field to nutritional recommendations.
structure that do not alter the DNA sequence, but confer transcriptional regulation over a range of timescales [4] . The major epigenetic processes are DNA methylation, histone modification and noncoding RNAs. To date, most studies on the interaction between nutrition and epigenetic regulation of genes have focused on DNA methylation, although there are emerging findings about other epigenetic marks. Methylation at the 5' position of cytosine in DNA within a CpG dinucleotide is a common modification in mammalian genomes and constitutes a stable epigenetic mark that is transmitted through DNA replication and cell division [5] . Methylation of CpG dinucleotides de novo is catalysed by DNA methyltransferases (Dnmts) 3a and 3b, and is maintained through mitosis by locus-specific methylation of hemimethylated DNA by Dnmt1 [6] .
DNA methylation can induce transcriptional silencing by blocking the binding of transcription factors and/or through promoting the binding of the methyl CpG-binding protein (MeCP2) [6] , which in turn, recruits histone-modifying complexes to the DNA. MeCP2 recruits both histone deacetylases (HDACs) and histone methyl transferases (HMTs) resulting in a closed chromatin structure and transcriptional silencing [7] [8] [9] [10] . Dnmt1 is recruited by HDACs and HMTs suggesting that chromatin structure may also determine DNA methylation status [11] [12] [13] , which confers the potential for dynamic changes in the regulation of genes in response to environmental stimuli including nutrition.
Epigenetic marks associated with cell phenotype are essentially maintained throughout life. However, there are emerging findings which show that epigenetic plasticity may extend beyond early development to include periods in the life course associated with rapid physiological change such as puberty and aging [14] . This suggests the possibility that epigenotypes associated with disease risk can be modified.
NUTRITION, EPIGENETICS AND THE EARLY LIFE ORIGINS OF DISEASE
There is substantial evidence to support the hypothesis that the early life environment, including nutrition, can influence future risk of disease [15] . There are increasing data in both animal models and humans, which indicate a causal role epigenetic process in the early life origins of disease [16] .
Evidence from studies of animal models Recent studies continue to report associations between nutrition in early life, and future epigenotype and phenotype.
The effects of maternal dietary fat Feeding pregnant rats a diet containing 45% energy as corn oil induced in the fetus hypermethylation and reduced expression of the homeodomaincontaining factor A10 in osteogenic calvarial cells [17 & ]. This was associated with the formation of mature osteoblasts. Although altered epigenetic regulation of parentally imprinted genes, those in which either the maternal or paternal copy is silence by methylation of its promoter, is known to induce marked physical abnormalities [18] , this is the first study to show that the effects of maternal diet on epigenetic processes can potentially alter morphogenesis by modifying the expression of nonimprinted genes.
Feeding rats a diet containing 45% energy from an undisclosed type fat from conception until gestational day 20 induced increased fetal blood glucose concentration [19] . This was accompanied by higher mRNA expression of gluconeogenic genes in fetal liver including phosphoenolpyruvate carboxykinase (PEPCK), glucose-6-phosphatase and PPARg coactivator-1a (PGC-1a). Histones at the PEPCK gene showed lower dimethyl-H3K4, tri-methyl-H3K9, acetylated-H3 in the promoter and offspring, whereas acetylated-H4 and dimethyl-H3K4 were increased in the coding region. The role of DNA methylation was not explored. A recent study showed that the amount, rather than the type of fat in the maternal diet was the major factor for inducing epigenetic change in the offspring. Feeding diets containing 21% (w/w) fat derived from safflower oil, butter, hydrogenated soybean oil or fish oil during pregnancy and lactation in rats induced hypermethylation of a specific CpG dinucleotide in the Fads2 promoter and lower expression of D6 desaturase in the aortae of the offspring compared with those whose dams were fed 7% (w/w) fat [20 silencing of the Hnf4a promoter in pancreatic islet cells, which has been implicated in T2DM, by both DNA methylation and histone modifications at the P2 promoter leading to weakening of the P2 promoter-enhancer, which was followed by progressive transcriptional suppression of the entire Hnf4a locus as the offspring aged. These findings represent an expansion of the mechanisms by which nutrition during development is known to induce long-term changes in phenotype. Others have reported increased GLUT4 expression [22] and sex-related changes in CCAAT/enhancer-bindingprotein (C/EBP)-b expression [23 & ] associated with specific histone modifications in muscle of the offspring of rats fed a PR diet during pregnancy. Feeding pregnant rats a PR diet also induced hypomethylation of specific CpG dinucleotides in the adipose tissue leptin promoter [24] and in the heart PPARa promoter in adult offspring [25] .
The effect of nutrients involved in 1-carbon metabolism Epigenetic processes are associated intimately with 1-carbon metabolism and modifications of dietary intakes of specific nutrients involved in methyl group provision, in particular folate, are known to alter the epigenetic regulation of genes [16] . McKay et al. [26, 27, 28 & ] reported the effects of variation in maternal folic acid in mice intake on DNA methylation of cells in the gut of the offspring. Maternal, but not postweaning, low folic acid intake induced global DNA hypomethylation in the small intestine of the female offspring [28 & ]. Low maternal folic acid intake was associated with sex-specific differences in the methylation of slc394a and Esr in the offspring gut [27] . In rats, supplementation of the maternal diet or the diet of the juvenile offspring with folic acid induced altered methylation of specific CpG dinucleotides in the hepatic PEPCK promoter of adult female, but not male, offspring [29 && ]. These findings suggest that the nature of the epigenetic change induced by a specific nutrient intervention may depend upon the animal species, sex, genotype and target gene as well as timing of exposure and direction of nutritional change. Such factors may represent a substantial challenge for extrapolating nutrient effects on epigenetic processes observed in animal models to humans and for targeting nutritional interventions to induce specific epigenetic changes.
Other nutritional exposures during early life Schaible et al. [30] found that supplementation of pregnant mice with folic acid, cobalamin, betaine and choline increased susceptibility in the offspring to dextran-sulphate-induced colitis. This was accompanied by altered expression and DNA methylation of a number of genes in the offspring intestine. Magnesium deficiency in pregnant rats induced hypermethylation of specific CpG dinucleotides in the hydroxysteroid dehydrogenase-2 promoter.
EVIDENCE FROM STUDIES OF HUMAN COHORTS
The victims of the Dutch Hunger Winter (DHW) are one of a few cohorts for which the precise nature and duration of the nutritional challenge during development is known [31] . Igf2 was hypomethylated while nonimprinted genes including leptin, ATP binding cassette A1, were hypermethylated in whole blood DNA of individuals, who were exposed to famine in utero compared with unexposed samesex siblings [32, 33] . The biological significance of the relatively small (around 6%) absolute difference in methylation is not clear, although the methylation status of the nonimprinted loci predicted risk of myocardial infarction in women [34] .
Godfrey et al. [35 & ] reported a positive association between the methylation status of a specific CpG locus in the retinoid-x-receptor-a (RXRa) in the umbilical cord that explained of 25% of the variation in childhood fat mass at 6 or 9 years in two cohorts and was related to maternal carbohydrate intake during pregnancy. The same group also showed a positive association between methylation of a specific CpG locus in the eNOS promoter and child's whole-body bone area, bone mineral content, and areal bone mineral density at age 9 years [36] . Relton et al. [37 & ] have found that a 1% increase in the methylation of a single locus in the alkaline phosphatase gene in umbilical cord blood was associated with 0.15% decrease in height at 9 years.
The mechanism by which the methylation status of single CpG loci in a complex tissue such as umbilical cord tissue or blood is associated with phenotypic outcomes in childhood is not known. However, these studies suggest the possibility that epigenetic marks present at birth may act as predictors for future disease risk and so pave the way for screen tools to improve health outcomes.
EPIGENETICS AND NONGENOMIC TRANSMISSION OF TRAITS BETWEEN GENERATIONS
Passage of induced phenotypic traits between generations via nongenomic processes is well known amongst plants and animal species [38] . However, the mechanism underlying the passage of traits between generations is not well understood. One recent study investigated the passage of epigenetic marks between generations in rats exposed to 25% increase in total energy from conception in F0 to adult F3 offspring. The findings showed that epigenetic and phenotypic changes in the liver PEPCK and Dnmt3a promoters of F1 offspring were modified in the F2 and F3 offspring [39 & ]. This suggested adjustment to the nutritional challenge, possibly as a consequence of changes in the interaction between maternal phenotype and her diet in each generation sending different signals to the fetus [39 & ]. Similarly, exposure of mice to increased methyl donor intakes over six generations progressively increased the number of CpG loci with altered methylation [40 & ]. Together these findings suggest epigenetic variation may be one mechanism by which environmental factors acting through developmental plasticity may contribute to adaptation of organisms to novel environments.
Epigenetics and type 2 diabetes mellitus in humans
A number of studies have investigated the role of epigenetics in adult humans with T2DM. Differential methylation of specific CpG loci in the PGC-1a gene promoter in pancreatic b cells has been shown to be associated with insulin secretion in patients with T2DM [41] . In blood leukocytes, a single CpG locus in intron 1 of the FTO gene had 3.4% lower methylation in adults with established T2DM compared with controls [42 && ] independent of polymorphisms associated with increased risk of T2DM. However, others have demonstrated genotypeepigenotype interactions in the FTO T2DM and obesity locus [43] . Furthermore, this CpG locus was hypomethylated in individuals, who had normal glucose metabolism at 30 years of age, but developed impaired glucose homeostasis by 43 years of age [43] . In methylation of specific CpG loci the insulin promoter in human pancreatic islets was also associated negatively with its transcription and positively with Hba(1c) concentrations [44] . Furthermore, 276 CpG loci in 254 genes have been found to be differentially methylated in pancreatic islets between controls and patients with T2DM, although differential methylation at these loci could not be detected in leukocytes [45 & ]. In twins, increased global DNA methylation in leukocytes has also been associated with increased insulin resistance, even when confounding by genetic factors was eliminated [46] . Together these findings support the suggestion of epigenetic marks associated with T2DM and may be induced before onset of symptoms and thus may have predictive value of future disease risk.
Epigenetics and exercise
Two studies have investigated the effect of exercise on DNA methylation. Zhang et al. [47 & ] have shown that in leukocytes global methylation was higher in individuals, who undertook physical activity for 26-30 min per day, compared with those who engaged in activity for less than 10 min, although this difference was lost after multivariate analysis. In contrast, volunteers who underwent incremental acute exercise to fatigue showed an exercise-dependent change in PGC-1a, PDK4 and PPAR-d mRNA expression in skeletal muscle, accompanied by significant hypomethylation of their promoters [48 && ]. Identification of acute epigenetic changes in adults further supports the suggestion that epigenetic plasticity constitutes beyond the early developmental period, at least for some genes. Furthermore, these findings also suggest the possibility that short-term changes in DNA methylation may contribute altered in metabolic regulation in response to acute physiological challenge.
Epigenetics, nutrition and cancer
The causal role of epigenetics in cancer is well established and is characterised by hypomethylation of proto-oncogenes and hypermethylation of tumour suppressor genes, and is largely associated with aging [49] . However, cancer risk reflects events across the life course and epigenetic changes associated with cell transformation may be present years before the onset of clinical disease [49] . Consistent with this hypothesis, methylation of the breast cancer-associated gene (BRCA)-1 in peripheral blood is associated with a 3.5-fold [95% confidence interval (CI), 1.4-10.5] increased risk of early onset breast cancer [50] . Other studies have shown that resveratrol prevents hypermethylation and silencing of BRCA1 in MCF-7 cells [51] and that the folic acid supplementation of lymphoblastoid cell lines altered the expression of over 100 genes and which, for some, was associated with changes in promoter methylation [52] . Eicosapentaenoic acid, but not oleic acid, induced demethylation of a single CpG dinucleotide in the promoter of the tumour suppressor gene C/EBP-d which corresponded to a known SP1 response element in U937 leukaemia cells [53 & ]. This study represents the first report of a specific effect of a polyunsaturated fatty acid on the epigenetic regulation of a gene.
Piyathilake et al. [54] have shown that global DNA methylation in leukocytes was higher in human papillomavirus-positive women who did not have cervical intraepithelial neoplasia than in cases, and that the level of leukocyte methylation was positively-associated with plasma folate and cobalamin concentration. Zeng et al. found that variation in the methylation of the tumour suppressor gene L3MBTL1 was associated with overall survival [55] .
Although nutritional interventions that modify epigenetic marks may be beneficial, these nutrientepigenome effects need to be demonstrated in vivo in order to determine their implications for cancer risk.
CONCLUSION
Epigenetics is still a relatively new science in which the availability of tools and understanding of the key processes of inheritance and gene regulation is substantially behind conventional genetics. Furthermore, with a few exceptions, the impact of genetic and epigenetic variation on transcription and phenotype has yet to be determined. However, the field is progressing rapidly and the findings reported during the last 12 months reflect advances in understanding and in analytical technologies. There is increasing evidence that nutrition throughout the life course modifies the epigenome and that such variation is involved in differential risk of a number of important diseases. Furthermore, epigenetic processes also affect how the body uses nutrients. Therefore, if nutritional recommendations are to be targeted at individuals then epigenetic effects must be included in any attempt at personalised nutrition. One important contrast between nutrigenomics and epinutrigenomics is that polymorphisms associated with harmful traits need to be accommodated within the nutritional recommendation. However, the continuing plasticity of the epigenome throughout the life course raises the possibility of nutritional interventions to correct epigenetic 'errors' and thus reduced disease risk.
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